Sit Investment Associates’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
Other funds holding XYL
Sit Investment Associates's XYL Position: Q2 2026 in Review
Sit Investment Associates increased its Xylem (XYL) stake by 23% in Q2 2026, buying an estimated $1.47M and bringing the position to 68,995 shares worth $8.16M. The position accounts for 0.15% of the portfolio, ranked #160.
Sit Investment Associates first reported a position in XYL in Q4 2023 and has held it in 11 quarters since. The position peaked at $10.5M in Q3 2025. 1,096 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- Sit Investment Associates held 68,995 shares of Xylem worth $8.16M as of Q2 2026.
- Sit Investment Associates bought 12,770 Xylem shares in Q2 2026, an estimated $1.47M.
- Xylem made up 0.15% of Sit Investment Associates's portfolio in Q2 2026, its #160 holding.
- Sit Investment Associates first reported a position in Xylem in Q4 2023 and has held it in 11 quarters since.
- Sit Investment Associates's Xylem position peaked at $10.5M in Q3 2025.
- 1,096 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on Sit Investment Associates's 13F filing for Q2 2026, filed 12 Aug 2026.